[Federal Register: March 17, 2005 (Volume 70, Number 51)]
[Notices]               
[Page 13033-13037]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17mr05-59]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Building Comprehensive Prevention Program Planning and Evaluation 
Capacity for Rape Prevention and Education Funded Programs

    Announcement Type: New.
    Funding Opportunity Number: RFA 05037.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates:
    Letter of Intent Deadline: April 18, 2005.
    Application Deadline: May 16, 2005.

I. Funding Opportunity Description

    Authority: This program is authorized under section 393B of the 
Public Health Service Act (42 U.S.C. section 280b).
    Purpose: The Centers for Disease Control and Prevention (CDC) 
announces the availability of a fiscal year 2005 cooperative agreement 
to build comprehensive prevention program planning and evaluation 
capacity among selected Rape Prevention and Education (RPE) funded 
sexual violence prevention programs and to assess short-term and 
intermediate capacity building outcomes for each program. Prevention 
program planning and evaluation will be focused on the national Rape 
Prevention and Education Program logic model as well as comprehensive 
primary prevention strategies. In May 2004 CDC completed an 
evaluability assessment of the national RPE program. One of the key 
recommendations of the evaluability assessment is to build capacity for 
prevention program planning and evaluation among funded recipients.
    Specific purposes of this funding are to:
    1. Increase the capacity of selected Rape Prevention and Education 
funded programs to engage in comprehensive prevention program planning 
for their state Rape Prevention and Education Program.
    2. Increase the capacity of selected Rape Prevention and Education 
funded programs to develop and implement an evaluation of their state 
Rape Prevention and Education Program.
    3. Increase the capacity of selected Rape Prevention and Education 
funded programs to sustain program planning and evaluation efforts 
after this cooperative agreement has ended.
    4. Assess short-term and intermediate program planning and 
evaluation capacity building outcomes for each program.
    5. Disseminate lessons learned to assist sexual violence prevention 
practitioners in programmatic decision making and evaluation.
    For the purposes of this program announcement the following 
definition applies:
    Sexual Violence: Any sexual act, attempt to obtain a sexual act, 
unwanted sexual comments or advances, or acts to traffic, or otherwise 
directed, against a person's sexuality using coercion, by any person 
regardless of their relationship to the victim, in any setting, 
including but not limited to home or work (Jewkes, R., Sen, P. and 
Garcia-Moreno, C., 2002).
    This program addresses the ``Healthy People 2010'' focus area(s) of 
Injury and Violence Prevention.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC):
    Increase the capacity of injury prevention and control programs to 
address the prevention of injuries and violence.
    This announcement is only for non-research activities supported by 
CDC/ATSDR. If research is proposed, the application will not be 
reviewed. For the definition of research, please see the CDC Web site 
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm
.

    Activities:
    Awardee activities for this project are as follows:
    a. Maintain current or increased level of program activities and 
staffing.
    b. Convene a state prevention team that includes agencies, 
organizations and individuals who can inform the program planning and 
evaluation process.
    c. Collaborate with CDC, CDC identified consultant(s) and the state 
prevention team in developing a comprehensive prevention program and 
evaluation plan for their state Rape Prevention and Education Program.
    d. Contract with an in-state evaluator to assist the state 
prevention team in comprehensive program planning and evaluation 
efforts. The evaluator should operate from an empowerment evaluation 
framework to increase state capacity regarding comprehensive program 
planning and evaluation. The evaluator is expected to attend program 
planning and evaluation trainings provided by CDC and CDC identified 
consultant(s). The evaluator should be hired, or an internal evaluator 
identified, by March 2006.
    e. Collaborate with CDC, the CDC identified consultant(s), the in-
state

[[Page 13034]]

evaluator, and the state prevention team on developing and/or 
implementing planning and evaluation tools.
    f. Participate in routine program planning and evaluation training 
provided by CDC and CDC identified consultant(s) with other funded 
programs in a centralized location. The evaluation contractor, the 
health department grantee and at least one person from the state 
prevention team should attend these trainings.
    g. Participate in training and technical assistance site visits 
with CDC and CDC identified consultant(s).
    h. Participate in ongoing technical assistance and consultation 
with CDC and CDC identified consultant(s).
    i. Participate with other grantees, CDC, and CDC identified 
consultant(s) in monthly conference calls.
    j. Participate in a baseline and follow-up assessment of grantee 
program planning and evaluation capacity with CDC and CDC identified 
consultant(s).
    k. Collaborate with CDC and other grantees on an ongoing basis by 
sharing lessons learned, tools and progress.
    l. Disseminate lessons learned to local, state and national 
partners via multiple mechanisms such as conferences, meetings and 
reports.
    m. Dedicate at least a .50 FTE to coordinate and support the state 
prevention team through planning and evaluation efforts, supervise and 
coordinator with staff and the evaluation contractor, collaborate with 
CDC and the CDC identified consultant(s), participate in monthly 
conference calls, travel to meetings, etc.
    n. Submit reports to CDC as required.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC activities for this program are as follows:
    a. Contract with relevant expert consultant(s) to provide funded 
programs with intensive comprehensive prevention program planning and 
evaluation training and technical assistance, which may include any of 
the following:
    i. Making site visits to each program for the purpose of ongoing 
technical assistance.
    ii. Training program staff in the use of logic models, evidence-
based program planning, building comprehensive prevention programs, 
evaluation planning and implementation, etc.
    iii. Assisting program staff with planning and evaluation 
activities.
    iv. Conducting baseline and follow-up assessments of grantee 
program planning and evaluation capacity.
    b. Assist the CDC identified consultant(s) in providing funded 
programs with intensive training and technical assistance as noted 
above.
    c. Provide guidance on how to hire an evaluation contractor and 
approve the hire of applicant's evaluation contractor.
    d. Coordinate information sharing among relevant CDC grantees and 
partners via multiple settings such as in-person meetings and regular 
conference calls.
    e. Disseminate lessons learned to local, state and national 
partners via multiple mechanisms such as conferences, meetings and 
reports.

II. Award Information

    Type of Award: Cooperative Agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Fiscal Year Funds: 2005.
    Approximate Total Funding: $400,000.
    Approximate Number of Awards: 4.
    Approximate Average Award: $100,000.
    Floor of Award Range: $100,000.
    Ceiling of Award Range: $100,000 (This ceiling is for the first 12-
month budget period.)
    Anticipated Award Date: September 1, 2005.
    Budget Period Length: 12 months.
    Project Period Length: three years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

III.1. Eligible Applicants

    Applications may be submitted by the health departments of states 
and territories who are current recipients of Rape Prevention and 
Education funding.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    CDC will accept and review applications with budgets greater than 
the ceiling of the award range.
Special Requirements
    If your application is incomplete or non-responsive to the special 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.
     Late applications will be considered non-responsive. See 
section ``IV.3. Submission Dates and Times'' for more information on 
deadlines.
     Note: Title 2 of the United States Code Section 1611 
states that an organization described in Section 501(c)(4) of the 
Internal Revenue Code that engages in lobbying activities is not 
eligible to receive Federal funds constituting an award, grant, or 
loan.

IV. Application and Submission Information

IV.1. Address To Request Application Package

    To apply for this funding opportunity use application form PHS 
5161-1.
Electronic Submission
    CDC strongly encourages you to submit your application 
electronically by utilizing the forms and instructions posted for this 
announcement on http://www.Grants.gov, the official Federal agency wide E-

grant Web site. Only applicants who apply online are permitted to 
forego paper copy submission of all application forms.
Paper Submission
    Application forms and instructions are available on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.

    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.
    Pre-Application Conference Call:
    For interested applicants, one pre-application technical assistance 
call will be conducted on March 31, 2005 from 2-3 pm EST. Please e-mail 
Karen Lang at klang@cdc.gov by March 24, 2005 to request the conference 
call number and code. The conference call number and code will be 
provided via e-mail.

IV.2. Content and Form of Submission

Letter of Intent (LOI)

Electronic Submission
    You may submit your LOI electronically at: http://www.grants.gov by 

filling out the required Grants.gov information and attach a word 
document.
    Your LOI must be written in the following format:
     Maximum number of pages: one
     Font size: 12-point unreduced
     Single spaced
     Paper size: 8.5 by 11 inches
     Page margin size: One inch
     Printed only on one side of page

[[Page 13035]]

     Written in plain language, avoid jargon
    Your LOI must contain the following information:
     Name of Organization

Application

Electronic Submission
    You may submit your application electronically at: http://www.grants.gov.
 Applications completed online through Grants.gov are 

considered formally submitted when the applicant organization's 
Authorizing Official electronically submits the application to 
http://www.grants.gov. Electronic applications will be considered as having 

met the deadline if the application has been submitted electronically 
by the applicant organization's Authorizing Official to Grants.gov on 
or before the deadline date and time.
    It is strongly recommended that you submit your grant application 
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel, 
etc.). If you do not have access to Microsoft Office products, you may 
submit a PDF file. Directions for creating PDF files can be found on 
the Grants.gov Web site. Use of file formats other than Microsoft 
Office or PDF may result in your file being unreadable by our staff.
    CDC recommends that you submit your application to Grants.gov early 
enough to resolve any unanticipated difficulties prior to the deadline. 
You may also submit a back-up paper submission of your application. Any 
such paper submission must be received in accordance with the 
requirements for timely submission detailed in section IV.3. of the 
grant announcement. The paper submission must be clearly marked: 
``Back-up for Electronic Submission.'' The paper submission must 
conform to all requirements for non-electronic submissions. If both 
electronic and back-up paper submissions are received by the deadline, 
the electronic version will be considered the official submission.
Paper Submission
    If you plan to submit your application by hard copy, submit the 
original and two hard copies of your application by mail or express 
delivery service. Refer to section IV.6. Other Submission Requirements 
for submission address.
    You must submit a program narrative with your application forms. 
The narrative must be submitted in the following format:
     Maximum number of pages: 15. If your narrative exceeds the 
page limit, only the first pages, which are within the page limit, will 
be reviewed. Budget justification does not count towards page limit.
     Font size: 12 point unreduced
     Double spaced
     Paper size: 8.5 by 11 inches
     Page margin size: One inch
     Printed only on one side of page
     Held together only by rubber bands or metal clips; not 
bound in any other way.
    Your narrative should address activities to be conducted over the 
entire project period, and must include the following items in the 
order listed:
     Background and need for planning and evaluation assistance
     Program Description
     Capacity and Staffing
     Collaboration
     Measures of effectiveness
     Proposed budget and justification (does not count towards 
page limit)
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit. This additional information includes:
     Logic model of program
     Relevant planning documents
     Curriculum Vitaes or Resumes
     Organizational Charts
     Memorandum of Understanding from state prevention team 
members
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-

5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
.

    If your application form does not have a DUNS number field, please 
write your DUNS number at the top of the first page of your 
application, and/or include your DUNS number in your application cover 
letter.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    LOI Deadline Date: April 18, 2005.
    CDC requests that you send a LOI if you intend to apply for this 
program. Although the LOI is not required, not binding, and does not 
enter into the review of your subsequent application, the LOI will be 
used to gauge the level of interest in this program, and to allow CDC 
to plan the application review.
    Application Deadline Date: May 16, 2005.
    Explanation of Deadlines: LOI's and applications must be received 
in the CDC Procurement and Grants Office by 4 p.m. eastern time on the 
deadline date. If you submit your LOI and application by the United 
States Postal Service or commercial delivery service, you must ensure 
that the carrier will be able to guarantee delivery by the closing date 
and time. If CDC receives your submission after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the submission as having 
been received by the deadline.
    This announcement is the definitive guide on LOI and application 
content, submission address, and deadline. It supersedes information 
provided in the application instructions. If your submission does not 
meet the deadline above, it will not be eligible for review, and will 
be discarded. You will be notified that you did not meet the submission 
requirements.
Electronic Submission
    If you submit your application electronically with Grants.gov, your 
application will be electronically time/date stamped which will serve 
as receipt of submission. In turn, you will receive an e-mail notice of 
receipt when CDC receives the application. All electronic applications 
must be submitted by 4 p.m. eastern time on the application due date.
Paper Submission
    CDC will not notify you upon receipt of your paper submission. If 
you have a question about the receipt of your LOI or application, first 
contact your courier. If you still have a question, contact the PGO-TIM 
staff at: 770-488-2700. Before calling, please wait two to three days 
after the submission deadline. This will allow time for submissions to 
be processed and logged.

IV.4. Intergovernmental Review of Applications

    Executive Order 12372 does not apply to this program.

[[Page 13036]]

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     Funds may not be used for research.
     Reimbursement of pre-award costs is not allowed.
     Budgets for the first period should include travel costs 
for the health department grantee, one person from the state prevention 
team and the evaluation contractor to attend up to three 2-day training 
meetings in Atlanta, Georgia with CDC staff, other cooperative 
agreement grantees, and the CDC identified consultant(s).
     Budgets for the first period should include an evaluation 
contractor to be identified (internal staff) and hired (contractor) by 
March 2006.
     Funds for this project cannot be used for construction.
     Funds for this project cannot be used for renovation.
     Funds for this project cannot be used for the lease of 
passenger vehicles.
     Funds for this project cannot be used for the development 
of major software applications.
     Funds for this project cannot be used for supplanting 
current applicant expenditures.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement.
    If your indirect cost rate is a provisional rate, the agreement 
should be less than 12 months of age.
    Guidance for completing your budget can be found on the CDC Web 
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.


IV.6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or E-mail to: Karen Lang, National Center for Injury 
Prevention and Control, 4770 Buford Hwy, NE., Mailstop K-60, Atlanta, 
GA 30341; Phone: 770/488-1118; FAX: 770/488-1360; klang@cdc.gov.
Electronic Submission
    LOIs may be submitted electronically at this time to http://www.Grants.gov.
 Fill out the required Grants.gov information and attach 

a word document with the necessary information from IV.2. Content and 
Form of Submission.

Application Submission Address

Electronic Submission
    CDC strongly encourages applicants to submit electronically at: 
http://www.Grants.gov. You will be able to download a copy of the 

application package from http://www.Grants.gov, complete it offline, and then 

upload and submit the application via the Grants.gov site. E-mail 
submissions will not be accepted. If you are having technical 
difficulties in Grants.gov they can be reached by E-mail at http:http://www.support@grants.gov">
//www.support@grants.gov or by phone at 1-800-518-4726 (1-800-518-


GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m. 
eastern time, Monday through Friday.
Paper Submission
    If you chose to submit a paper application, submit the original and 
two hard copies of your application by mail or express delivery service 
to: Technical Information Management--RFA 05037, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.

V. Application Review Information

V.1. Criteria

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the ``Purpose'' section of 
this announcement. Measures must be objective and quantitative, and 
must measure the intended outcome. These measures of effectiveness must 
be submitted with the application and will be an element of evaluation.
    Your application will be evaluated against the following criteria:
1. Program Description (35 Points)
    a. Does the applicant provide a description of their state Rape 
Prevention and Education Program that includes coordinated state-level 
initiatives and partnerships, local program components; program goals, 
objectives and desired outcomes; and staff capacity?
    b. Does the applicant describe the training and technical 
assistance provided to RPE grantees and other partners?
    c. Does the applicant provide a description of their RPE program 
planning efforts to date? Are the applicant's planning efforts intended 
to advance comprehensive prevention programs in the state?
    d. Does the applicant describe current program evaluation 
activities (including methods and tools) and any findings that are 
available?
    e. Does the applicant include relevant supporting documents such as 
a logic model or other graphic depiction of their program's intended 
purpose and projected outcomes, a state plan for the RPE program, 
meeting summaries or minutes from recent planning meetings, or 
evaluation findings?
2. Collaboration (30 Points)
    a. Does the applicant describe the roles and responsibilities of 
all members of the state prevention team and provide memoranda of 
understanding from all team members?
    b. Do the memoranda of understanding indicate a commitment to and 
understanding of the mission and vision of the national RPE program?
    c. Does the state prevention team include the state sexual assault 
coalition and other individuals, agencies and organizations that can 
inform the comprehensive program planning and evaluation process for 
the state RPE Program?
    d. Does the applicant demonstrate a successful history of 
collaborating effectively with organizations at the local and state 
levels?
3. Capacity and Staffing (25 Points)
    a. Does the applicant dedicate at least a .50 FTE to the prevention 
program planning and evaluation project?
    b. Does the applicant demonstrate an existing capacity and 
infrastructure, including the involvement of management level staff, to 
carry out the required activities in the cooperative agreement?
    c. Does the applicant describe the relevant skills/expertise and 
responsibilities of individual staff members, levels of effort and 
allocation of time?
    d. Does the applicant indicate they will be able to identify an 
internal evaluator or contract with an in-state evaluator within the 
specified timeframe (March 2006)?
4. Background and Need for Planning and Evaluation Assistance (10 
Points)
    a. Does the applicant describe resident planning and evaluation 
capacity and how this capacity building project will develop program 
staff and partner's prevention program planning and evaluation capacity 
and skills?
    b. Does the applicant describe how this program planning and 
evaluation capacity building project will improve their state Rape 
Prevention and Education program?
5. Measures of Effectiveness (Not Scored)
    Does the applicant provide objective/quantifiable measures 
regarding the intended outcomes that will

[[Page 13037]]

demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement?
6. Budget (Not Scored)
    Does the applicant provide a detailed budget with complete line-
item justification of all proposed costs consistent with the stated 
activities in the program announcement? Details must include a 
breakdown in the categories of personnel (with time allocations for 
each), staff travel, communications and postage, equipment, supplies, 
and any other costs? Does the budget projection include a narrative 
justification for all requested costs? Any sources of additional 
funding beyond the amount stipulated in this cooperative agreement 
should be indicated, including donated time or services. For each 
expense category, the budget should indicate CDC share, the applicant 
share and any other support. These funds should not be used to supplant 
existing efforts.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff and for responsiveness by the National 
Center for Injury Prevention and Control (NCIPC). Incomplete 
applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above. The objective review panel will be comprised of CDC 
employees from inside and outside the National Center for Injury 
Prevention and Control.
    Applications will be funded in order by score and rank determined 
by the review panel. CDC will provide justification for any decision to 
fund out of rank order.

V.3. Anticipated Announcement and Award Dates

    Anticipated Announcement Date: May 15, 2005.
    Anticipated Award Date: September 1, 2005.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Award (NOA) from the 
CDC Procurement and Grants Office. The NOA shall be the only binding, 
authorizing document between the recipient and CDC. The NOA will be 
signed by an authorized Grants Management Officer, and mailed to the 
recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

    45 CFR part 74 and part 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.

    An additional Certifications form from the PHS5161-1 application 
needs to be included in your Grants.gov electronic submission only. 
Refer to: http://www.cdc.gov/od/pgo/funding/PHS5161-1-Certificates.pdf. 

Once the form is filled out attach it to your Grants.gov submission as 
Other Attachments Form.
    The following additional requirements apply to this project:
     AR-10 Smoke-Free Workplace Requirements
     AR-11 Healthy People 2010
     AR-12 Lobbying Restrictions
     AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities
    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.


VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, due no less than 90 days before the end 
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following 
elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Budget.
    e. Measures of Effectiveness.
    f. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management or Contract 
Specialist listed in the ``Agency Contacts'' section of this 
announcement.

VII. Agency Contacts

    We encourage inquiries concerning this announcement.
    For general questions, contact: Technical Information Management 
Section, CDC Procurement and Grants Office, 2920 Brandywine Road, 
Atlanta, GA 30341; Telephone: 770/488-2700.
    For program technical assistance, contact: Karen Lang, Project 
Officer, National Center for Injury Prevention and Control, 4770 Buford 
Hwy, NE., Mailstop K-60, Atlanta, GA 30341; Telephone: 770-488-1118; E-
mail: klang@cdc.gov.
    For financial, grants management, or budget assistance, contact: 
Brenda Hayes, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341; Telephone: 770-488-
2741; Fax: 770/488-2670; E-mail: BHayes@cdc.gov.

VIII. Other Information

    This and other CDC funding opportunity announcements can be found 
on the CDC Web site, Internet address: http://www.cdc.gov. Click on 

``Funding'' then ``Grants and Cooperative Agreements.''

    Dated: March 11, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-5283 Filed 3-16-05; 8:45 am]

BILLING CODE 4163-18-P